Noah G. Levy, Director at MERRIMACK PHARMACEUTICALS INC (MACK), bought 6,600 shares at $11.24 ($74K) on 2023-01-03, disclosed to the SEC on 2023-01-04.
Open-market purchase of $74k MACK by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.24 | 1,300 | $15K | 19.7% |
| 2 | $11.24 | 5,300 | $60K | 80.3% |
| Total | $11.24 avg | 6,600 | $74K | 100% |
| Filing → |
| MACK | BUY | 2022-07-05 | $9K | — | Filing → |
| MACK | BUY | 2022-06-14 | $81K | — | Filing → |
| MACK | BUY | 2022-01-28 | $353K | — | Filing → |